Continuing follow-up of malignant hypertension

Journal of Nephrology

Volumn 15, Issue 4, 2002, Pages 431-437

  Scarpelli, Paolo Tommaso ^a   Gallo, Marco ^a   De Cesaris, Francesco ^a   Chiari, Gianna ^a   Dedola, Gianluca ^a   Cappelli, Stefania ^a   Becucci, Aureliano ^a   Becherelli, Paola ^a   Tosi, Benedetta ^a   Fanetti, Carla ^a   Fanelli, Roberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Accelerated hypertension; BP self measurements; Renal protection

Indexed keywords

ANTIHYPERTENSIVE AGENT; CLONIDINE; CREATININE; DIURETIC AGENT; HYDRALAZINE;

ANAMNESIS; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG EFFECT; DRUG MEGADOSE; ESSENTIAL HYPERTENSION; FOLLOW UP; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LONG TERM CARE; MALIGNANT HYPERTENSION; NEPHROSCLEROSIS; PREVALENCE; PROTECTION; RELAPSE; SELF EXAMINATION; SURVIVAL;

ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, MALIGNANT; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEPHROSCLEROSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 0036659433     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Scarpelli PT, Livi R, Caselli GM, Di Maria L, Teghini L, Montemurro V. Toti G, Becucci A. Accelerated (malignant) hypertension: a study of 121 cases between 1974 and 1996. J Nephrol 1997; 10: 207-15.
2. Liebreich R. Ophtalmoskopischer Befund bei morbus Brightii. Graefes Arch Klin Exp Ophthalmol 1859; 5: 265.
3. von Graefe A. Nächtregliche Bemerkung über sclerotico-chorioideitis posterior. Graefes Arch Klin Exp Ophthalmol 1854-1855; 1 (2 Abt): 307.
4. Bright R. Cases and observations illustrative of renal disease accompanied with the secretion of albuminous urine. Guy's Hosp Rep 1836; 1: 338-79.
5. Wilks S. Cases of Bright's disease with remarks. Guy's Hosp Rep 1853. 8: 232-315.
6. Bartels C. Structural diseases of the kidney and the general symptoms of renal affections. In: H. von Ziemssen, Ed. Cyclopaedia of the Practice of Medicine. Tr. by R. Southey and R. Bertolet. London, Sampson Low 1877; 15: 3.
7. Johnson G. I On certain points in the anatomy and pathology of Bright's disease of the kidney. II On the influence of the minute blood-vessels upon the circulation. Med Chir Trans 1868; 51: 57-76.
8. Gull WW. Chronic Bright's disease with contracted kidney (arterio-capillary fibrosis). Br Med J 1872; 2: 673-4.
9. Gull WW, Sutton HG. On the pathology of the morbid state commonly called chronic Bright's disease with contracted kidney ("Arterio-capillary fibrosis"). Med Chir Trans 1872; 55: 273-326.
10. Ziegler E. Über die Ursachen der Nieren Schrumpfung nebst Bemerkungen über die Unterscheidung verschiedener Formen der Nephritis. Dtsch Arch Klin Med 1880; 25: 585.
11. Ewald CA. Über die Veränderungen kleiner Gefäße bei Morbus Brightii und die darauf bezüglichen Theorien. Virchows Arch Pathol Anat Physiol Klin Med 1877; 71: 453.
12. Mahomed FA. The physiology and clinical use of the sphygmograph. Med Times Gazette 1872; 1: 62.
13. Mahomed FA. The etiology of Bright's disease and the prealbuminuric stage. Med Chir Trans 1874; 57: 197-228.
14. Mahomed FA. The sphygmographic evidence of arterio-capillary fibrosis. Trans Pathol Soc 1877; 28: 394.
15. Mohamed FA. Remarks on the arterio-capillary and its clinical recognition. Lancet 1877; 2: 232.
16. Mohamed FA. On chronic Bright's disease, and its essential symptoms. Lancet 1879; I: 46.
17. Mohamed FA. Some of the clinical aspects of chronic Bright's disease. Guy's Hosp Rep 1879; 24: 363.
18. Mahomed FA. Chronic Bright's disease without albuminuria. Guy's Hosp Rep 1881; 25: 295.
19. Pickering G. Systemic arterial hypertension. In "Circulation of the Blood. Men and ideas". Fishman AP and Richards DW Eds. Published by Am Physiol Soc 1982; 487-541.
20. Allbutt TC. Rise of blood pressure in later life. Med Chir Trans 1904; 86: 323-43.
21. Frank E. Bestehen Bezichungen zwischen chromaffinem System und der chronischen Hypertonie des Menschen. Ein kritischer Beitrag zu der Lehre von der physio-pathologischen Bedeutung des Adrenalins. Dtsch Arch Klin Med 1911; 103: 397.
22. Pickering G. The First Volhard Lecture. Franz Volhard, 1872-1972. Clin Sci Mol Med 1973. 45 (suppl 1): S1-10.
23. Volhard F, Fahr T. Die Brightsche Nieren krankheit. Klinik, Pathologie und Atlas. Springer, Berlin 1914.
24. Byrom FB. The hypertensive vascular crisis. Heinemann Med. Books, London 1969.
25. Volhard F. On the pathogenesis of red (essential) arterial hypertension and of malignant nephrosclerosis (Festschrift for Thomas Addis). Stanford Med Bull 1948; 6: 13-28.
26. Laragh JH. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med 1973; 55: 261-74.
27. Wagener HP, Keith NM. Cases of marked hypertension, adequate renal function and neuroretinitis. Arch Intern Med 1924; 34: 374.
28. Derow HA, Atlschule MD. Malignant hypertension. N Engl J Med 1935; 213: 951-60.
29. Schurmann P, McMahon HE. Die maligne nephrosklerose, zugleich ein beitrag zur frage der bedeutung der blutgewebsschranke. Virchows Arch 1933; 291: 47-218.
30. Bohle A, Grund KE, Helmchen U, Meyer D. Primary malignant nephrosclerosis. Clin Sci Mol Med 1976; 3 (suppl): S23-5.
31. Bohle A, Muller GA, Wehrmann M, Mackensenhaen S, Xiao Jia-Cheng. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int 1996; 49 (suppl 54): S2-9.
32. Pickering GW, Wright AD, Heptinstall RH. The reversibility of malignant hypertension. Lancet 1952; II: 952.
33. Ellis A. Malignant Hypertension. Lancet 1938; I: 977-80.
34. Burst AA, Pereira GA, Wilkins RW. Council on drugs. Report to the council: classification of types of hypertension. JAMA 1958; 166: 640-1.
35. Davis BA, Crook JE, Vestal RE, Oates JA. Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N Engl J Med 1979; 301: 1273-6.
36. Gifford RW. Management and treatment of malignant hypertension and hypertensive emergencies. In: Hypertension, Genest J Ed., McGraw-Hill Med Health 1977; 1024-38.
37. Kaplan NM. Hypertensive crises. In: Kaplan NM Ed: Clinical Hypertension, IV Ed., William and Wilkins, Baltimore, 1987; 273-91.
38. Perez Stable EC, Materson BJ. Workup of the newly discovered hypertensive patients. Postgrad Med J 1975; 57: 109-13.
39. Woods JW. Malignant hypertension: clinical recognition and management. Cardiovasc Clin 1978; 9: 311-20.
40. Hricik DE, Wright JT Jr, Smith MC. Hypertension Secrets, Hanley and Belfus, Philadelphia 2002.
41. Lee TH, Aldermann MH. Malignant hypertension. Declining mortality rate in New York City, 1958 to 1974. New York State J Med 1978; 78: 1389-91.
42. Lip GYH, Beevers M, Beevers GD. The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England. J Hypertens 1994; 12: 1297-305.
43. Edmunds E, Beevers DG, GYH Lip. What has happened to malignant hypertension? A disease no longer vanishing. J Hum Hypertens 2000; 14: 159-61.
44. Zampaglione B, Pascale P, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies: prevalence and clinical presentation. Hypertension 1996. 27: 144-7.
45. Perry HM, Freis ED, Frohlich ED. Department of Veterans Affairs hypertension meeting: a proposal for improved care. Hypertension 2000; 35: 853-7.
46. Frohlich ED. State of hypertension as we enter in the 21st century: a societal conundrum. Hypertension 2000; 35: 1177-8.
47. AAVV. United States Renal Data Report. USRDR Coordinating Center, Minneapolis 2000.
48. Zanchetti A, Stella A. Cardiovascular disease and the kidney: an epidemiologic overview. J Cardiovasc Pharmacol 1999; 33 (suppl 1): S1-6.
49. Keith NM, Wagener P, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939; 197: 332-43.
50. Smith DE, Ode HM, Kernohorn JW. Causes of death in hypertension. Am J Med 1950; 516-27.
51. Perry HM Jr, Schroeder HA. The effect of treatment on mortality rates in severe hypertension. A comparison of medical and surgical regimens. Arch Intern Med 1958; 102: 418-25.
52. Dustan HP, Schmeckloth RE, Corcoran AC, Page IH. The effectiveness of long-term treatment of malignant hypertension. Circulation 1958; 18: 644-51.
53. Harrington M, Kincaid-Smith P and MacMichael J. Results of treatment in malignant hypertension. Br Med J 1959; 2: 969-80.
54. Sokolow M, Perloff D. Five-years survival of consecutive patients with malignant hypertension treated with antihypertensive agents. Am J Cardiol 1960; 6: 858-63.
55. Bjork S. The effect of active drug treatment in severe hypertensive disease. Acta Med Scand 1961; 169: 673-89.